{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/THCT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"THCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THCT\",,,,,undefined,":{"symbol":"THCT","market":"US","secType":"STK","nameCN":"THC Therapeutics, Inc.","latestPrice":0.0004,"timestamp":1754337600000,"preClose":0.0004,"halted":0,"volume":0,"delay":15,"floatShares":28334518,"shares":38866149,"eps":-0.016463,"marketStatus":"Pre-Mkt","change":0,"latestTime":"08-04 16:00:00 EDT Delay","open":0.0004,"high":0.0004,"low":0.0004,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.016463,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1754400600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0004,"volumeRatio":3.067779001813911},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"THCT\",,,,,undefined,":{"symbol":"THCT","floatShares":28334518,"roa":"-2855.54%","roe":"22.47%","lyrEps":-0.011797,"volumeRatio":3.067779001813911,"shares":38866149,"dividePrice":0,"high":0.0004,"amplitude":0,"preClose":0.0004,"low":0.0004,"week52Low":0.0001,"pbRate":"-0.00","week52High":0.0167,"institutionHeld":0,"latestPrice":0.0004,"eps":-0.016463,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.016463,"open":0.0004,"prevYearClose":0.0009,"prevWeekClose":0.0004,"prevMonthClose":0.0001,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0002,"sixtyDayClose":0.0003},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/THCT\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"THCT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552100028","title":"THC Therapeutics Acquires Iconic Oregon Cannabis Brand SugarTop Buddery in $3M All-Share Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2552100028","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552100028?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:01","pubTimestamp":1752746478,"startTime":"0","endTime":"0","summary":"THC Therapeutics, Inc. has announced its acquisition of SugarTop Buddery, a prominent cannabis brand based in Eugene, Oregon. The transaction, valued at approximately $3 million, was completed through the issuance of newly created Series D Preferred stock. This acquisition enhances THCT's presence in Oregon and supports its strategy to establish a bi-coastal, vertically integrated national cannabis platform. Anna Kaplan, CEO of SugarTop Buddery, expressed optimism about the growth opportunities and the ability to engage new markets on the East Coast. This marks THCT's second strategic acquisition, following its recent purchase of The Headquarters Group. SugarTop Buddery, founded in 2015, is celebrated for its community-driven and music-inspired approach to cannabis, emphasizing artistry, equity, and sustainability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL5CWLJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","THCT","BK1230","00656"],"gpt_icon":0},{"id":"2550576637","title":"Thc Therapeutics Inc - Buys Sugartop Buddery for $3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2550576637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550576637?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:30","pubTimestamp":1752064200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nTUA48MVXN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THCT","BK4082"],"gpt_icon":0},{"id":"2550375466","title":"Thc Therapeutics, Inc. Announces Acquisition of Sugartop Buddery","url":"https://stock-news.laohu8.com/highlight/detail?id=2550375466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550375466?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:30","pubTimestamp":1752064200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nTUA48MVXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THCT","BK4082"],"gpt_icon":0},{"id":"2546742231","title":"THC Therapeutics Inc. Acquires The Headquarters Group, Expanding Presence in Oregon and California Cannabis Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2546742231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546742231?lang=en_us&edition=fundamental","pubTime":"2025-06-27 22:49","pubTimestamp":1751035769,"startTime":"0","endTime":"0","summary":"THC Therapeutics, Inc. has announced the acquisition of The Headquarters Group, Inc., consolidating its position in the legal cannabis industry. The transaction, valued at approximately $11 million, was completed through the issuance of 11,007 thousand shares of Series D Preferred stock. This strategic move unites THC Therapeutics with The Headquarters Group, a company with over 60 years of combined experience in genetics, cultivation, extraction, and distribution, as well as specialty real estate and nutrients for cannabis growers. The acquisition includes companies with a combined revenue of $4.8 million and is intended to maximize efficiencies and generate significant revenue through a fully integrated vertical cannabis platform.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDLnPlqJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","THCT"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/THCT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"THCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"THCT\",market:\"US\",delay:false,,,undefined,":{}}}